Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

NLRP3 Antibody Blocking peptide

NLRP3 Antibody Blocking peptide

Product Specifications

Product Name Alternative

NACHT, LRR and PYD domains-containing protein 3, Angiotensin/vasopressin receptor AII/AVP-like, Caterpiller protein 11, CLR11, Cold autoinflammatory syndrome 1 protein, Cryopyrin, PYRIN-containing APAF1-like protein 1, NLRP3, C1orf7, CIAS1, NALP3, PYPAF1

UniProt

Q96P20

Field of Research

Cell Biology

Form

Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Notes

For research use only.

Applications Notes

Synthetic peptide

AA Sequence

The synthetic peptide sequence used to generate the antibody orb1928431 was selected from the N-term region of human NLRP3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Human Protein canopy homolog 2, CNPY2 ELISA Kit
MBS9335154-01 48 Well

Human Protein canopy homolog 2, CNPY2 ELISA Kit

Sign In for Pricing
View Details
Human Protein canopy homolog 2, CNPY2 ELISA Kit
MBS9335154-02 96 Well

Human Protein canopy homolog 2, CNPY2 ELISA Kit

Sign In for Pricing
View Details
Human Protein canopy homolog 2, CNPY2 ELISA Kit
MBS9335154-03 5x 96 Well

Human Protein canopy homolog 2, CNPY2 ELISA Kit

Sign In for Pricing
View Details
Human Protein canopy homolog 2, CNPY2 ELISA Kit
MBS9335154-04 10x 96 Well

Human Protein canopy homolog 2, CNPY2 ELISA Kit

Sign In for Pricing
View Details
Anti-human IGF1R / CD221 (Cixutumumab Biosimilar)
orb2829144-01 1 mg

Anti-human IGF1R / CD221 (Cixutumumab Biosimilar)

Sign In for Pricing
View Details
Anti-human IGF1R / CD221 (Cixutumumab Biosimilar)
orb2829144-02 5 mg

Anti-human IGF1R / CD221 (Cixutumumab Biosimilar)

Sign In for Pricing
View Details